Difference between revisions of "Amir Attaran"
Bob Burton (talk | contribs) m (Reverted edit of 61.48.107.177, changed back to last version by Bob Burton) |
|||
Line 5: | Line 5: | ||
He is currently Associate Professor of Law and Population Health, and the holder of a prestigious Canada Research Chair at the University of Ottawa, Canada. Previously he was an adjunct lecturer in Public Policy at Harvard University, publishing research as part of the Center for International Development and the Carr Center for Human Rights Policy at the John F. Kennedy School of Government. | He is currently Associate Professor of Law and Population Health, and the holder of a prestigious Canada Research Chair at the University of Ottawa, Canada. Previously he was an adjunct lecturer in Public Policy at Harvard University, publishing research as part of the Center for International Development and the Carr Center for Human Rights Policy at the John F. Kennedy School of Government. | ||
− | He is a board member of [[Africa Fighting Malaria]], a private organization funded in part by the American Enterprise Institute. He has been a vocal critic against the humanitarian organization Doctors Without Borders for its | + | He is a board member of [[Africa Fighting Malaria]], a private organization funded in part by the American Enterprise Institute. He has been a vocal critic against the humanitarian organization Doctors Without Borders for factual errors in its campaign information on drug patents and medicine access, and is a critic of the WHO's Roll Back Malaria campaign, having earned international recognition for a paper in The Lancet which forced WHO to transform the treatment of malaria from older and ineffective drugs to newer highly effective ones, which WHO credits with saving a large number of childrens' lives. |
==References== | ==References== |
Revision as of 17:32, 4 September 2005
Dr. Amir Attaran is a lawyer (LL.B., Vancouver) and immunologist (DPhil, Oxford) who writes on public health and global development issues. He has been published in journals such as Nature, the Lancet, the Journal of the American Medicial Association, the Yale International Law Journal, and also in the New York Times, the Globe and Mail, and other publications. His coauthors include development economist Jeffrey Sachs, and Nobel peace prize laureate Shirin Ebadi.
Dr. Attaran has been a paid consultant to NGOs (e.g. Doctors Without Borders), the United Nations (e.g. the UNDP), the pharmaceutical industry (e.g. Novartis), and an unpaid consultant when requested by various developing country governments (e.g. Brazil, Malawi). All his sources of research financing are fully disclosed in his peer-reviewed publications.
He is currently Associate Professor of Law and Population Health, and the holder of a prestigious Canada Research Chair at the University of Ottawa, Canada. Previously he was an adjunct lecturer in Public Policy at Harvard University, publishing research as part of the Center for International Development and the Carr Center for Human Rights Policy at the John F. Kennedy School of Government.
He is a board member of Africa Fighting Malaria, a private organization funded in part by the American Enterprise Institute. He has been a vocal critic against the humanitarian organization Doctors Without Borders for factual errors in its campaign information on drug patents and medicine access, and is a critic of the WHO's Roll Back Malaria campaign, having earned international recognition for a paper in The Lancet which forced WHO to transform the treatment of malaria from older and ineffective drugs to newer highly effective ones, which WHO credits with saving a large number of childrens' lives.
References
- Consumer Project on Technology, Big Pharma's favorite academics and opinion makers, accessed February 2004.
- A Critique of Amir Attaran's claims about patents and medicine access, [1], [2], [3].
- Royal Institute of International Affairs, Dr Amir Attaran, biography, accessed February 2004.
- Patent Politics, TAGline, Volume 8, Issue 9, November 2001.